To grow, cancer tumors must hijack the immune system for their needs. One of the main tricks that most tumors use is to ...

With a three-minute presentation on cancer research, Kirstin Rollins, a PhD student in the Department of Molecular, Cellular, ...

Research has shed light on how a new type of antibody treatment reactivates patients' immune cells to fight ovarian cancer.

CAR-M is an individualized therapy that begins with isolation of ... dendritic cells (DCs), and repolarizing tumor-associated macrophages (TAMs) toward an M1 phenotype. In addition to direct ...

A new review published in Genes & Diseases highlights macrophage-targeted therapy as a promising frontier in cardiac regeneration and myocardial repair. The findings underscore the critical role ...

Neurona Therapeutics has circled up $102 million to push its off-the-shelf cell therapy for epilepsy through phase 3 testing.

This study provides proof-of-principle data for the use of trained immunity to modulate macrophage interactions with tumours. The study makes a valuable contribution to the field of trained immunity.

Researchers have found a new way to boost cancer immunotherapy by targeting a protein called macrophage receptor ... of immunotherapy known as anti-CTLA4 therapy, significantly enhances tumor ...

The macrophages also showcased morphological changes. “Looking at the world of cancer immunology and cell therapy, it is largely driven by biology. However, in addition to the biology of the cell, it ...

Biologic therapy was associated with more than seven times greater odds of reaching sustained remission compared with ...